Cargando…
HLA-DRB1(∗)0401 and HLA-DRB1(∗)0408 Are Strongly Associated with the Development of Antibodies against Interferon-β Therapy in Multiple Sclerosis
The formation of antibodies to interferon-beta (IFN-β), a protein-based disease-modifying agent for multiple sclerosis (MS), is a problem in clinical practice. These antibodies may neutralize the biological effects of the protein drug, potentially decreasing its therapeutic effects. By high-resoluti...
Autores principales: | Hoffmann, Steve, Cepok, Sabine, Grummel, Verena, Lehmann-Horn, Klaus, Hackermueller, Jörg, Stadler, Peter F., Hartung, Hans-Peter, Berthele, Achim, Deisenhammer, Florian, Wasmuth, Ralf, Hemmer, Bernhard |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2495071/ https://www.ncbi.nlm.nih.gov/pubmed/18656179 http://dx.doi.org/10.1016/j.ajhg.2008.07.006 |
Ejemplares similares
-
IFN-γ production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8
por: Berg, Louise, et al.
Publicado: (2000) -
Analog peptides of type II collagen can suppress arthritis in HLA-DR4 (DRB1*0401) transgenic mice
por: Sakurai, Yoshihiko, et al.
Publicado: (2006) -
Unique Clinical and Pathological Features in HLA-DRB1*0401–restricted MBP 111–129–specific Humanized TCR Transgenic Mice
por: Quandt, Jacqueline A., et al.
Publicado: (2004) -
Association of HLA-DRB1*11 and HLA-DRB1*12 gene polymorphism with COVID-19 in Burkina Faso
por: Ouedraogo, Alfred Rakissida, et al.
Publicado: (2023) -
A transplantable tumor model allowing investigation of NY-BR-1-specific T cell responses in HLA-DRB1*0401 transgenic mice
por: Das, Krishna, et al.
Publicado: (2019)